EXON 44

Clinical trials for EXON 44 explained in plain language.

Never miss a new study

Get alerted when new EXON 44 trials appear

Sign up with your email to follow new studies for EXON 44, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for boys with DMD: weekly infusion aims to restore muscle protein

Disease control Recruiting now

This study is testing a new drug called NS-089/NCNP-02 for boys with Duchenne muscular dystrophy (DMD) caused by a specific genetic error (exon 44). The drug is given as a weekly IV infusion and aims to help muscles produce more of a crucial protein called dystrophin. Researchers…

Matched conditions: EXON 44

Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

EXON 44

Get alerted when new EXON 44 trials appear

New hope for boys with DMD: weekly infusion aims to restore muscle protein